# CYCLONE 2 (NCT03706365)

> A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03706365
- Phase: PHASE2, PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Eli Lilly and Company
- Conditions: Prostate Cancer
- Interventions: Abemaciclib; Placebo; Abiraterone acetate; Prednisone
- Enrollment: 393
- Primary outcome: Radiographic Progression Free Survival (rPFS)

## Commentary we found

- X threads: 18
- Podcasts: 7
- YouTube: 2

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=cyclone-2-nct03706365

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT03706365", "email": "<work email>"}; the inbox owner confirms by the emailed link.